Alumis Inc Share Price

NASDAQ: ALMS

Small Cap

$4.14

-0.24

(-5.37%)

as on September 17, 2025 at 1:29 am IST

$₹

Alumis Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$4.15
Day's Price Range
$4.47
$4.14
-0.24%
Downside
7.97%
Upside
52 Week's Low
52 Week's High
$2.76
52-Week Price Range
$13.11
$4.14
33.33%
Downside
216.67%
Upside

Alumis Inc share price movements today

Previous Close: $4.38
Open: $4.37
Volume: 498.4K
Day's Low - High: $4.15 - $4.47
52 Week Low - High: $2.76 - $13.11

Alumis Inc Historical Returns

1 Month Return: -12.42 %
3 Month Return: + 38.21 %
1 Year Return: -60.79 %
3 Year Return: 0 %
5 Year Return: 0 %

Alumis Inc Stock Fundamentals & Key Indicators

Check Alumis Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$455.8M

EPS (TTM)

-3.08

Dividend Yield

0.00%

PE Ratio (TTM)

0.13

Industry PE ratio

P/B Ratio

0.132

PEG Ratio

Return On Equity TTM

-66.35%

Alumis Inc Stock Valuation

Track how Alumis Inc P/E has moved over time to understand its valuation trends.

Alumis Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 17, 2025

Industry (0.00x)

September 17, 2025

Today (0.13x)

September 17, 2025

Highest (-0.89x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 0.13x

Alumis Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alumis Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Alumis Inc	NA	$455.8M	NA	0.13	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Alumis Inc Stock including INR - Dollar returns

The Alumis Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Alumis Inc investment value today

Current value as on today

₹43,618

Returns

₹56,382

(-56.38%)

Returns from Alumis Inc Stock

₹60,980 (-60.98%)

Dollar Returns*

₹4,598 (+4.6%)

Alumis Inc Stock's Interest Amongst Investors

Search interest for Alumis Inc Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:-54% versus previous 30 day period

Alumis Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	3	17	2
Gross Profit	0	0	0	0	0	0	0	1	17	2
Operating Income	-36	-37	-43	-40	-47	-56	-98	-98	-101	-140
EBITDA	-36	-37	-43	-39	-46	-55	-97	-97	-100	-140
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	-	-
Income Before Tax	-36	-36	-43	-39	-49	-56	-93	-94	-98	50
Income Tax Expense	-	-	-	-	-	-	-	-	-	-8
Net Income	-36	-36	-43	-39	-49	-56	-93	-94	-98	59
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-3121.18%	-569.11%	2225.09%

Alumis Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-
Gross Profit	0	-1	-3
Operating Income	-113	-158	-300
EBITDA	-113	-156	-297
Interest Expense	-	-	-
Depreciation	0	1	3
Income Before Tax	-111	-154	-294
Income Tax Expense	-	-	-
Net Income	-111	-154	-294
Net Profit Margin	0.00%	0.00%	0.00%

Alumis Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-36	-43	-39	-49	-56	-93	-94	-98	59
Operating Cash Flow	-28	-33	-33	-44	-52	-83	-74	-80	-106
Investing Cash Flow	25	7	-4	-18	-32	-93	30	39	129
Financing Cash Flow	59	0	29	129	128	235	0	-	0
Change in Cash	57	-25	-8	66	43	58	-43	-40	23

Alumis Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2023	Dec 2024
Net Income	-154	-294
Operating Cash Flow	-129	-255
Investing Cash Flow	60	-113
Financing Cash Flow	89	492
Change in Cash	20	123

Insights on Alumis Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 128.9%
NEGATIVE IMPACT
Price Dip
In the last 1 month, ALMS stock has moved down by -12.4%

About Alumis Inc

Alumis Inc. is a late-stage biopharmaceutical company. The Company is engaged in developing next-generation targeted therapies with the potential to significantly improve patient health and outcomes across a range of immune-mediated diseases. Leveraging its proprietary data analytics platform and precision approach, the Company is developing a pipeline of oral tyrosine kinase 2 (TYK2) inhibitors, consisting of ESK-001 for the treatment of systemic immune-mediated disorders, such as moderate-to-severe plaque psoriasis and systemic lupus erythematosus, and A-005 for the treatment of neuroinflammatory and neurodegenerative diseases such as multiple sclerosis and Parkinson’s Disease. In addition, its pipeline also includes lonigutamab, a subcutaneously delivered anti-insulin-like growth factor 1 receptor therapy for the treatment of thyroid eye disease, as well as several preclinical programs identified through this precision approach.

Organisation	Alumis Inc
Headquarters	280 East Grand Avenue, South San Francisco, CA, United States, 94080
CEO	Mr. Martin Babler Ph.D.
E-voting on shares	Click here to vote

Key Management of Alumis Inc

Name	Title
Mr. Martin Babler Ph.D.	President, CEO & Chairman
Dr. David M. Goldstein Ph.D.	Chief Scientific Officer
Mr. Roy C. Hardiman J.D.	Chief Business & Strategy Officer
Mr. John R. Schroer C.F.A.	Chief Financial Officer
Ms. Sanam Pangali J.D.	Chief Legal Officer & Corporate Secretary

FAQs

What is Alumis Inc share price today?

Alumis Inc share price today is $4.14 as on September 17, 2025 at 1:29 am IST at the close of the market. Alumis Inc share today touched a day high of $4.47 and a low of $4.15.

What is the 52 week high and 52 week low for Alumis Inc share?

Alumis Inc share touched a 52 week high of $13.11 on October 21, 2024 and a 52 week low of $2.76 on June 24, 2025. Alumis Inc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $4.14,which is 68.42% down from its 52 week high and 49.99% up from its 52 week low.

What is Alumis Inc's market capitalisation today?

Alumis Inc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Alumis Inc Stock (ALMS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Alumis Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alumis Inc Shares that will get you 0.3623 shares as per Alumis Inc share price of $4.14 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Alumis Inc Stock (ALMS) from India?

Indian investors can start investing in Alumis Inc (ALMS) shares with as little as ₹87.816 or $1 (as of September 17, 2025 at 5:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Alumis Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 5:39 pm IST). Based on Alumis Inc share’s latest price of $4.14 as on September 17, 2025 at 1:29 am IST, you will get 2.4155 shares of Alumis Inc. Learn more about fractional shares .